Trudell Medical

What Trudell Medical does

Trudell Medical International Inc. is a privately held Canadian medical device company founded in 1922 in London, Ontario, that develops and manufactures pharmaceutical aerosol drug delivery devices for human and animal health. Its core product lines include valved holding chambers (AEROCHAMBER family), breath-actuated nebulizers (AEROECLIPSE BAN series), oscillating positive expiratory pressure devices (AEROBIKA), peak flow meters (TRUZONE), and integrated dose counters (AEROCOUNT) for metered dose inhalers. The technology stack centers on aerosol science and mechanical design, validated through an in-house aerosol laboratory, 300+ patents, and 300+ peer-reviewed publications, with products differentiated by features such as anti-static chamber materials, flow indicators, and breath-actuated delivery that reduce medication waste. The company holds ISO 13485:2016 certification and participates in ISO/TC84/JWG5 standards development.

The business operates under the Trudell Medical Group umbrella, which encompasses six operating companies and more than 900 employees globally, including wholly owned subsidiaries in the UK, Europe, Australia, and the US (Monaghan Medical). Revenue is generated through three primary streams: (1) hardware sales of respiratory devices via direct-to-consumer e-commerce (trudellmed.com), Canadian pharmacy retail, healthcare professional/institutional field sales, and an international distribution network covering 110+ countries; (2) licensing/royalty-style revenue from AEROCOUNT dose counters embedded into pharmaceutical partners' approved MDI drug products; and (3) accessories including compressors, silicone masks, and tubing. Pricing is unit-based at CAD $34.95-$59.95 for consumer chambers, with selected provincial and private insurance reimbursement available with prescription.

Ownership is concentrated in the Baran family, with George T. Baran serving as Executive Chairman following Mitchell A. Baran's death in 2015; no institutional or public shareholders are evidenced. The company is pursuing growth through the 2024 acquisition of Vyaire Medical's RDx respiratory diagnostics unit, prior acquisitions of Aetonix (2020) for digital health and Monaghan Medical (1980) for US manufacturing, and ongoing new product introductions including the AEROCHAMBER2GO portable chamber. Geographic expansion continues through regional offices in Egypt and Japan, while sustainability positioning (EcoVadis Bronze Medal 2025, Net Zero by 2040 commitment) supports institutional procurement eligibility.

Name

Trudell Medical

Legal name

Trudell Medical International Inc.

Website

https://trudellmed.com

Company type

Private

Founded year

1922

Operating status

Operating

Headcount range

51–100 employees

Short description

Trudell Medical International manufactures respiratory drug delivery devices including valved holding chambers, breath-actuated nebulizers, OPEP airway clearance devices, and peak flow meters, serving patients with asthma, COPD, and other chronic respiratory conditions across 110+ countries.

Ownership category

akta.pro rank

Product category

Respiratory Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE)

akta.pro secondary industries

Inhalers (MDI/DPI/SMI) (HLAHAIAI), Nebulizers & Aerosol Drug Delivery Systems (HLAHAIAJ)

Keywords

• Respiratory medical devices
• Aerosol drug delivery
• Valved holding chambers
• Nebulizer systems
• Airway clearance devices

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Direct sales of respiratory medical devices to patients, healthcare providers, and through pharmacy distribution. Products include spacers, nebulizers, OPEP devices, peak flow meters, dose counters, compressors, masks, and accessories.
2. Pharmaceutical Partnership Products: AEROCOUNT dose counter integrated into pharmaceutical MDI drug products, developed in partnership with pharmaceutical companies for drug delivery systems.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Trudell Medical International (TMI) designs, develops, and manufactures pharmaceutical aerosol drug delivery devices for human and animal health. The product portfolio centers on valved holding chambers (AEROCHAMBER family), breath-actuated nebulizers (AEROECLIPSE), oscillating positive expiratory pressure devices (AEROBIKA), peak flow meters (TRUZONE), and integrated dose counters (AEROCOUNT) for metered dose inhalers, complemented by compressors, masks, and tubing accessories.

Product overview

Trudell Medical International is a manufacturer of respiratory drug delivery and lung health devices. The product portfolio centers on aerosol/inhaler therapy products including valved holding chambers (AEROCHAMBER family), nebulizers (AEROECLIPSE BAN series), oscillating PEP devices (AEROBIKA), and peak flow meters (TRUZONE), complemented by supporting compressors, masks, and tubing. Products are marketed and distributed in over 110 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• AEROCHAMBER: Family of valved holding chambers (spacers) for use with metered dose inhalers
• AEROBIKA
• AEROECLIPSE
• TRUZONE
• AEROCOUNT
• COMFORTSEAL
• OMBRA
• myAero Community
• EZ TWIST

Products and services

• AEROCHAMBER PLUS FLOW-VU Chamber Valved holding chamber (spacer) for use with metered dose inhalers, featuring FLOW-VU inhalation indicator and FLOWSIGNAL whistle to confirm proper technique and improve medication delivery to the lungs.
• AEROBIKA OPEP Device Drug-free oscillating positive expiratory pressure device for airway clearance that helps open weak airways and loosen mucus for patients with COPD, bronchiectasis, and cystic fibrosis. Features 5 resistance settings.
• AEROCHAMBER2GO Chamber Portable 2-in-1 valved holding chamber that doubles as an inhaler storage case for on-the-go use by adolescents and adults. Available only in Canada.
• AEROECLIPSE XL BAN Nebulizer Breath-actuated nebulizer that produces aerosol only during the inhalation cycle, reducing medication waste. Six-month reusable device designed for home use.
• AEROECLIPSE II BAN Nebulizer Breath-actuated nebulizer with green feedback button indicating aerosol production during inhalation. Seven-day reusable device with mode selector for breath-actuated or continuous operation.
• TRUZONE Peak Flow Meter

Quantifiable outcome

• 2x increase in mean lung deposition when using AEROCHAMBER spacer with MDI compared to MDI alone
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Vyaire Medical (RDx business unit)coreStrategic or Co-development Partner · 22 August 2024Trudell Medical Limited announced agreement to acquire Vyaire Medical's RDx business unit, which manufactures respiratory diagnostic products used globally. The acquisition aims to expand Trudell's market position in respiratory diagnostics. The purchase is subject to court approval and RDx will operate as a separate unit in Germany and California. Deal expected to close in 8-12 weeks pending approval.

Scale indicators10 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Philips Respironics: A division of Philips offering CPAP/BiPAP, ventilators, nebulizers, and oxygen therapy. Competes directly with Trudell's respiratory drug delivery and OPEP portfolio and has a far larger hospital and homecare footprint.
• ResMed: Global leader in sleep and respiratory care devices (CPAP, ventilators, masks). Overlaps with Trudell's chronic respiratory disease franchise, particularly in COPD and airway clearance, with much greater scale and connected-health capabilities.
• Teleflex: Diversified medical device company with a respiratory portfolio including aerosol and oxygen therapy products. Broader scale and procedural adjacencies, with overlap in hospital respiratory consumables.
• Smiths Medical (ICU Medical): Now part of ICU Medical, Smiths Medical historically offered respiratory drug delivery and airway management products. Overlaps with Trudell in hospital-channel nebulization and respiratory consumables.

Direct peers

• PARI Medical: Specialist manufacturer of nebulizers and aerosol drug delivery systems for respiratory conditions. Closest direct competitor to Trudell's AEROECLIPSE breath-actuated nebulizer line and serves the same hospital, clinic, and home-care channels.
• Vyaire Medical: Respiratory diagnostics and ventilation company whose RDx business unit Trudell is acquiring. Strong overlap in respiratory diagnostics and consumables, with the RDx unit becoming part of Trudell post-close.
• Drive DeVilbiss Healthcare: Manufactures nebulizers, suction equipment, and respiratory care consumables. Competes with Trudell in compressor nebulizers and respiratory accessories, especially in the home-care and DME distribution channel.
• Allied Healthcare Products: Manufacturer of respiratory care products including nebulizers, oxygen equipment, and resuscitation devices. Direct competitor in hospital and emergency respiratory care, with overlapping product categories.

Emerging players

• Besmed Health Business: Manufacturer of respiratory care products including nebulizers, spacers, and masks. Direct overlap with Trudell's spacer and nebulizer portfolio, typically competing on price in the DME and pharmacy channel.

Regional players

• Inspira Health (animal/vet respiratory devices): Specialist in veterinary and human respiratory care devices. Comparable to Trudell Animal Health and the broader TMI portfolio in aerosol drug delivery for animal health, a niche extension of Trudell's respiratory franchise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/trudellmed
• Facebookfacebook.com/trudellmedical
• LinkedInlinkedin.com/company/trudell-medical-int

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trudell Medical